Editorial Staff

  • Executive Editor/VP-Special Projects:
    Jeff Hall
  • Senior Editor
    Brian McCurdy
  • Circulation and Subscriptions
    Bonnie Shannon
  • Art Director:
    Alana Balboni
  • Editorial Correspondence

  • Jeff Hall, Executive Editor/VP-Special Projects, Podiatry Today
  • HMP Communications, 83 General Warren Blvd
    Suite 100, Malvern PA 19355
  • Telephone: (800) 237-7285, ext. 214
    Fax: (610) 560-0501
  • Email: jhall@hmpcommunications.com
  • February 2013 | Volume 26 - Issue 2
    Valerie L. Schade, DPM, AACFAS
    7,554 reads | 0 comments | 01/24/13
    A myriad of products exists for the treatment of acute and chronic wounds. The primary goal with any of these products is rapid wound closure. Studies have shown that a lack of reduction in wound size at four weeks of treatment should prompt the provider to engage in advanced wound care modalities to accelerate the wound toward closure.1,2 ... continue reading

    4,100 reads | 0 comments | 01/24/13
    Two phase III studies, recently published in the Journal of the American Academy of Dermatology, say a new topical triazole antifungal may be a viable alternative to oral treatments for onychomycosis. ... continue reading
    Richard Pollak, DPM
    11,765 reads | 0 comments | 01/22/13
    Can an emerging topical hold promise for onychomycosis? This author takes a closer look in this case study of a 24-year-old patient with distal lateral subungual onychomycosis. ... continue reading